Loading…
Loading… fetching the latest figures.
Loading…
Loading… fetching the latest figures.
Company details aren't available for this ticker.
Johnson & Johnson (J&J) is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey. The company is ranked No. 42 on the 2026 Fortune 500 list of the largest United States corporations. In 2026, the company was ranked 43rd in the Forbes Global 2000. Along with Microsoft, Johnson & Johnson is one of only two U.S.-based companies that has a prime credit rating of AAA from S&P Global.
via Wikipedia →Annual figures from the company's own SEC filings. Tap any number to open the filing it came from.
| Fiscal year ending | Dec 2025 | Dec 2024 | Dec 2023 | Jan 2023 |
|---|---|---|---|---|
| RevenueGrowth = this year ÷ prior year − 1 | $94.2B+6.0% | $88.8B+4.3% | $85.2B+6.5% | $80.0B+1.6% |
| Net incomeMargin = net income ÷ revenue | $26.8B28.5% margin | $14.1B15.8% margin | $35.2B41.3% margin | $17.9B22.4% margin |
| Operating cash flowCash the business generated, vs net income above | $24.5B | $24.3B | $22.8B | $21.2B |
| Cash vs long-term debtCash − long-term debt. Excludes short-term borrowings and leases | — | -$6.5B$24.1B cash · $30.7B debt | -$4.0B$21.9B cash · $25.9B debt | -$14.0B$12.9B cash · $26.9B debt |
| Shares (weighted avg.)Change = this year ÷ prior year − 1 | 2.41B+0.0% | 2.41B-5.0% | 2.53B-3.5% | 2.63B-0.3% |
Automatic checks on the figures above. A flag is a pattern to investigate, not a finding of wrongdoing, and each one lists ordinary explanations for it.
None of the 1checks we could run on this company's figures were triggered.
See every flagged company in Market Watch →
Source: SEC EDGAR annual reports (Form 10-K), latest filed 2026-02-11. If a company later restates a year, the most recent filing is used. Dashes mean the company did not report that line in a form we could read. For information only, not investment advice.